DK0755403T3 - Fremgangsmåde til adskillelse af beskyttende komponenter fra Bordetalla pertussis - Google Patents

Fremgangsmåde til adskillelse af beskyttende komponenter fra Bordetalla pertussis

Info

Publication number
DK0755403T3
DK0755403T3 DK95917474T DK95917474T DK0755403T3 DK 0755403 T3 DK0755403 T3 DK 0755403T3 DK 95917474 T DK95917474 T DK 95917474T DK 95917474 T DK95917474 T DK 95917474T DK 0755403 T3 DK0755403 T3 DK 0755403T3
Authority
DK
Denmark
Prior art keywords
pertussis
bordetella pertussis
protective components
components
bordetella
Prior art date
Application number
DK95917474T
Other languages
Danish (da)
English (en)
Inventor
Akihiro Suehara
Eiji Yamamoto
Shigeo Fujii
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of DK0755403T3 publication Critical patent/DK0755403T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
    • C07K14/325Bacillus thuringiensis crystal peptides, i.e. delta-endotoxins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DK95917474T 1994-04-28 1995-04-26 Fremgangsmåde til adskillelse af beskyttende komponenter fra Bordetalla pertussis DK0755403T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP9156594 1994-04-28
PCT/JP1995/000830 WO1995029934A1 (en) 1994-04-28 1995-04-26 Method of separating protective components of bordetella pertussis

Publications (1)

Publication Number Publication Date
DK0755403T3 true DK0755403T3 (da) 2000-02-14

Family

ID=14030044

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95917474T DK0755403T3 (da) 1994-04-28 1995-04-26 Fremgangsmåde til adskillelse af beskyttende komponenter fra Bordetalla pertussis

Country Status (12)

Country Link
US (6) US6051240A (ko)
EP (1) EP0755403B1 (ko)
KR (1) KR100266556B1 (ko)
CN (1) CN1147259A (ko)
AT (1) ATE183194T1 (ko)
AU (1) AU2352595A (ko)
CA (1) CA2188424A1 (ko)
DE (1) DE69511392T2 (ko)
DK (1) DK0755403T3 (ko)
ES (1) ES2136290T3 (ko)
GR (1) GR3031481T3 (ko)
WO (1) WO1995029934A1 (ko)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8910570D0 (en) 1989-05-08 1989-06-21 Wellcome Found Acellular vaccine
US6444211B2 (en) * 1991-04-03 2002-09-03 Connaught Laboratories, Inc. Purification of a pertussis outer membrane protein
EP1233022B1 (en) * 1995-05-04 2015-12-09 Aventis Pasteur Limited Methods of preparation of components of acellular pertussis vaccines
US8574589B2 (en) * 2009-05-11 2013-11-05 Novartis Ag Antigen purification process for pertactin antigen
WO2011005587A1 (en) * 2009-06-24 2011-01-13 University Of Dubuque Vaccine compositions and methods of use to protect against infectious disease
CN102443572B (zh) * 2011-10-21 2012-12-19 武汉生物制品研究所有限责任公司 一种对脱毒后的百日咳疫苗抗原溶液进行纯化的方法
EP3270897A4 (en) * 2015-03-20 2018-12-05 The Regents Of The University Of Michigan Immunogenic compositions for use in vaccination against bordetella
CN114767718A (zh) * 2016-03-29 2022-07-22 里尔巴斯德研究所 突变型博德特氏菌属菌株及其使用方法
CN108570098B (zh) * 2017-12-29 2021-09-07 武汉生物制品研究所有限责任公司 一种百日咳多种抗原成分的分离纯化方法
CN110358802B (zh) * 2019-08-16 2021-06-18 长春百克生物科技股份公司 一种去除百日咳组分菌毛蛋白2/3内毒素的方法
WO2022114921A1 (ko) * 2020-11-30 2022-06-02 주식회사 엘지화학 알루미늄 부형제를 이용하여 다가 혼합백신 내 백일해 균 유래 엔도톡신 제거 방법

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5750925A (en) * 1980-09-12 1982-03-25 Takeda Chem Ind Ltd Preparation of pertussis toxoid
US4729957A (en) * 1984-12-13 1988-03-08 The United States Of America As Represented By The Department Of Health And Human Services Process for manufacture of L-asparaginase from erwinia chrysanthemi
GB8512972D0 (en) * 1985-05-22 1985-06-26 Univ Glasgow Vaccine production
GB8601279D0 (en) * 1986-01-20 1986-02-26 Public Health Lab Service Purification of pertussis antigens
CA1337859C (en) * 1987-04-24 1996-01-02 Masashi Chazono Method for culturing bordetella pertussis, a pertussis toxoid and a pertussis vaccine
US5101019A (en) * 1987-05-22 1992-03-31 Takeda Chemical Industries, Ltd. Method for removing pertussis endotoxin, a pertussis toxoid and its production
GB8807860D0 (en) * 1988-04-05 1988-05-05 Connaught Lab Pertussis vaccine
US5101014A (en) * 1989-02-10 1992-03-31 United States Of America Process for the purification of a 69,000 da outer membrane protein of Bordetella pertussis
ES2084668T3 (es) * 1989-11-06 1996-05-16 Smithkline Beecham Biolog Procedimiento.
US5276142A (en) * 1989-12-11 1994-01-04 American Cyanamid Company Process for purification of a 69000 dalton antigenic protein from Bordetella pertussis
GB9007657D0 (en) * 1990-04-04 1990-05-30 Connaught Lab Purification of a pertussis outer membrane protein(omp69)
IT1248735B (it) * 1990-06-21 1995-01-26 Sclavo Spa Vaccini acellulari contro la pertosse
EP0484621A3 (en) * 1990-07-11 1992-08-26 American Cyanamid Company Efficacious vaccines against bordetella pertussis comprising a combination of individually purified pertussis antigens
DK0669971T3 (da) * 1991-11-15 2003-04-22 Pfizer Fremgangsmåde til fremstilling af Gram-negative bakterielle vacciner
EP1233022B1 (en) * 1995-05-04 2015-12-09 Aventis Pasteur Limited Methods of preparation of components of acellular pertussis vaccines
US6696065B1 (en) * 1995-05-04 2004-02-24 Aventis Pastuer Limited Acellular pertussis vaccines and methods of preparation thereof

Also Published As

Publication number Publication date
DE69511392T2 (de) 2000-03-23
DE69511392D1 (de) 1999-09-16
CN1147259A (zh) 1997-04-09
US20030133941A1 (en) 2003-07-17
CA2188424A1 (en) 1995-11-09
US20050180987A1 (en) 2005-08-18
GR3031481T3 (en) 2000-01-31
WO1995029934A1 (en) 1995-11-09
KR100266556B1 (ko) 2000-09-15
EP0755403B1 (en) 1999-08-11
ATE183194T1 (de) 1999-08-15
KR970702874A (ko) 1997-06-10
ES2136290T3 (es) 1999-11-16
US6051240A (en) 2000-04-18
US20020119161A1 (en) 2002-08-29
US20100055134A1 (en) 2010-03-04
AU2352595A (en) 1995-11-29
EP0755403A1 (en) 1997-01-29
US20090068228A1 (en) 2009-03-12

Similar Documents

Publication Publication Date Title
DK0755403T3 (da) Fremgangsmåde til adskillelse af beskyttende komponenter fra Bordetalla pertussis
DK0869134T3 (da) Fremgangsmåde til udvinding af vækstfaktorer fra mælk eller et mælkederivat
CA2220048A1 (en) Acellular pertussis vaccines and methods of preparation thereof
UA43333C2 (uk) Спосіб очищення 10-дезацетилбаккатину ііі та таксотеру
ATE203057T1 (de) Verfahren zur industriellen herstellung von phosphatidylserine
SE0001128D0 (sv) A method of producing IgG
DK0522291T3 (da) Fremgangsmåde til rensning af hepatitis A-virus (HAV), således renset virus og vaccinepræparater indeholdende dette
SE8402861L (sv) Rening av biologiskt material
DK0527753T3 (da) Oprensning af et pertussis ydre membran-protein
ATE432946T1 (de) Abtrennung von fibrinogen von plasmaproteasen
ATE92335T1 (de) Reinigung von keuchhustenantigenen.
ATE438606T1 (de) Verfahren zur extrahierung, fraktionierung und reinigung mittels eines harzes mit hohem adsorptions- und eluierungsrendement, von polyphenolischen verbindungen erhalten aus ausleseabfällen von frischen gemüsen
DE50208601D1 (de) Verfahren zur aufreinigung von bakterienzellen und zellbestandteilen
YU78402A (sh) Hemostatički aktivni preparat koji sadrži vwf i postupak njegovog pripremanja
AR060686A1 (es) Purificacion de trombina
DE59108071D1 (de) Verfahren zur reinigung von abgasen, insbesondere aus abfallverbrennungsanlagen
TH20014A (th) วิธีการแยกส่วนประกอบป้องกันโรคไอกรนของ Bordetella pertussis
ATE375482T1 (de) Entfernung von verunreinigungen aus einem verunreinigten gas- oder dampfstrom
DK1456228T3 (da) Fremgangsmåde til isolering og rensning af trypsin fra pronase samt dens anvendelse
DE3577809D1 (de) Verfahren zur trennung von wasserstoffisotopen.
FR2432499A1 (fr) Procede de purification d'amines tertiaires
ES474611A1 (es) Procedimiento para aislar y purificar fosfato de poliribosilribitol inmunologicamente activo
SU865353A1 (ru) Способ очистки воздуха от Nн @ и кислых примесей
DK0778839T3 (da) Nye phosphanoxider, fremgangsmåde til deres fremstilling såvel som lægemidler indeholdende disse forbindelser
BR0201234A (pt) Métodos para purificação de nucleosìdeos de 2-desoxipurina 5'-protegida